Rapid and sustained improvement in itch in children aged 6 11 years with severe atopic dermatitis (AD) treated with dupilumab: Analysis from the LIBERTY AD PEDS phase 3 trial

被引：0

作者：

Paller, Amy S. ^{[1
]}

Siegfried, Elaine C. ^{[2
,3
]}

Yosipovitch, Gil ^{[4
]}

Silverberg, Jonathan I. ^{[5
]}

Wu, Jashin J. ^{[6
]}

Chen, Zhen ^{[7
]}

Prescilla, Randy ^{[8
]}

Rossi, Ana B. ^{[8
]}

Delevry, Dimittri ^{[7
]}

机构：

[1] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA

[2] St Louis Univ, St Louis, MO 63103 USA

[3] Cardinal Glennon Childrens Hosp, St Louis, MO USA

[4] Univ Miami, Miller Sch Med, Miami, FL 33136 USA

[5] George Washington Univ, Sch Med & Hlth Sci, Washington, DC 20052 USA

[6] Dermatol Res & Educ Fdn, Irvine, CA USA

[7] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA

[8] Sanofi Genzyme, Cambridge, MA USA

来源：

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

27389

引用

页码：AB140 / AB140

页数：1